Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of FDA Orange Book Patents covering 04276_SIAL

Client Email

Product

04276_SIAL
US Patents

Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

04276_SIAL

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

14 API Suppliers, 8 USDMF, 1 CEP/COS, 3 NDC API, 6 Listed Suppliers

14 API Suppliers
8 USDMF
1 CEP/COS
3 NDC API
6 Listed Suppliers

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

54 FDF Dossiers, 18 FDA Orange Book, 8 Europe, 9 Canada, 18 South Africa, 1 Listed Dossiers

54 FDF Dossiers
18 FDA Orange Book
8 Europe
9 Canada
18 South Africa
1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;IRRIGATION - 0.154MG/ML;0.92MG/ML;0.184MG/ML;0.2MG/ML;0.38MG/ML;2.1MG/ML;7.14MG/ML;0.42MG/ML, INJECTABLE;INJECTION - 3.68GM/1000ML;3.05GM/1000ML;0.314GM/1000ML ;3.09GM/1000ML;6.34GM/1000ML;0.187GM/1000ML (5000ML), INJECTABLE;INJECTION - N/A/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;6.95GM/1000ML;0.187GM/1000ML (5000ML)

SOLUTION;IRRIGATION - 0.154MG/ML;0.92MG/ML;0.184MG/ML;0.2MG/ML;0.38MG/ML;2.1MG/ML;7.14MG/ML;0.42MG/ML
INJECTABLE;INJECTION - 3.68GM/1000ML;3.05GM/1000ML;0.314GM/1000ML ;3.09GM/1000ML;6.34GM/1000ML;0.187GM/1000ML (5000ML)
INJECTABLE;INJECTION - N/A/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;6.95GM/1000ML;0.187GM/1000ML (5000ML)

RELATED EXCIPIENT COMPANIES

6 Rochem International Inc, 18 SPI Pharma, 2 Seqens, 4 DKSH, 2 Jai Radhe Sales, 3 Boai NKY Pharmaceuticals Ltd, 13 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 17 Actylis, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 17 BASF, 2 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 11 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 33 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 34 Roquette, 15 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

89 Fillers, Diluents & Binders, 54 Coating Systems & Additives, 40 Direct Compression, 29 Disintegrants & Superdisintegrants, 29 Thickeners and Stabilizers, 29 Controlled & Modified Release, 29 Parenteral, 27 Solubilizers, 26 Taste Masking, 22 Granulation, 20 Film Formers & Plasticizers, 19 Topical, 19 Lubricants & Glidants, 19 Co-Processed Excipients, 18 Chewable & Orodispersible Aids, 10 Emulsifying Agents, 9 API Stability Enhancers, 6 Surfactant & Foaming Agents, 5 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents, 1 Soft Gelatin

89 Fillers, Diluents & Binders
54 Coating Systems & Additives
40 Direct Compression
29 Disintegrants & Superdisintegrants
29 Thickeners and Stabilizers
29 Controlled & Modified Release
29 Parenteral
27 Solubilizers
26 Taste Masking
22 Granulation
20 Film Formers & Plasticizers
19 Topical
19 Lubricants & Glidants
19 Co-Processed Excipients
18 Chewable & Orodispersible Aids
10 Emulsifying Agents
9 API Stability Enhancers
6 Surfactant & Foaming Agents
5 Rheology Modifiers
5 Empty Capsules
4 Vegetarian Capsules
4 Coloring Agents
1 Soft Gelatin

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 5 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
5 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 8 Finished Drug Prices

2 US Medicaid Prescriptions
8 Finished Drug Prices

MARKET PLACE

14 APIs, 11 EXCIPIENTS, 1 Intermediates

14 APIs
11 EXCIPIENTS
1 Intermediates

PATENTS & EXCLUSIVITIES

1 US Patents

1 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM

2 EDQM

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

1 All

01 1SALIX PHARMS

filter Patent Number Reset all filters

1 All

01 17687075

filter API Patent Reset all filters

1 All

01 1Y

filter FDF Patent Reset all filters

1 All

01 1Y

filter Expiration Date Reset all filters

1 All

01 12028-06-22

Product Main Page

01

SALIX PHARMS

SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

AAPS 2024

Not Confirmed

SALIX PHARMS

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-06-22

SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

US Patent Number : 7687075

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21892

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-06-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?